SYRE vs W · $7.60B cap vs rev $6.45B
Spyre Therapeutics Inc. (SYRE) versus Wayfair Inc (W) — a side-by-side from cached financials, not a winner call.
Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
Wayfair Inc (W) is a internet retail company listed on NYSE.
Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.
Latest reported W revenue for 2026-06-30 was $6.45B. Net income was -$106.0M. W currently screens at market cap $10.77B.
SYRE currently screens at market cap $7.60B. W currently screens at market cap $10.77B.
Not investment advice. Open the SYRE and W stock pages for the full models.
Not investment advice.